Whistleblower: Mallinckrodt Concealed Vital Information to Drive Acthar Sales

Drug Industry Daily
A A
A whistleblower lawsuit accuses Mallinckrodt of systemically concealing concerns about the composition of its drug Acthar, indicated for treatment of infantile spasms.

To View This Article:

Login

Subscribe To Drug Industry Daily